Matsumoto Y, Kizaki H, Ikeda Y, Nakamura S, Kina S, Nagai T, Nasu T, Miyamoto K, Hori S. Telepharmacy in mountainous depopulated areas of Japan: an exploratory interview study of patients' perspectives. Drug Discov Ther. 2022 Jan 15;15(6):337-340.doi: 10.5582/ddt.2021.01102.
Ikegami K, Hashiguchi M, Kizaki H, Yasumuro O, Funakoshi R, Hori S. Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D3 )/Calcium Supplement. J Clin Pharmacol. 2022 Apr 5. doi: 10.1002/jcph.2057.
Mitsukura Y, Tazawa Y, Nakamura R, Sumali B, Nakagawa T, Hori S, Mimura M, Kishimoto T. Characteristics of single-channel electroencephalogram in depression during conversation with noise reduction technology. PLoS One. 2022 Apr 13;17(4):e0266518. doi: 10.1371/journal.pone.0266518.
Iino H, Hashiguchi M, Hori S. Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review. PLoS One. 2022 Apr 14;17(4):e0266934. doi: 10.1371/journal.pone.0266934.
Kizaki H, Yamamoto D, Satoh H, Masuko K, Maki H, Konishi Y, Hori S, Sawada Y. Analysis of contributory factors to incidents related to medication assistance for residents taking medicines in residential care homes for the elderly: a qualitative interview survey with care home staff. BMC Geriatr. 2022 Apr 22;22(1):352. doi: 10.1186/s12877-022-03016-4.
Nishioka S, Watanabe T, Asano M, Yamamoto T, Kawakami K, Yada S, Aramaki E, Yajima H, Kizaki H, Hori S. Identification of hand-foot syndrome from cancer patients' blog posts: BERT-based deep-learning approach to detect potential adverse drug reaction symptoms. PLoS One. 2022 May 4;17(5):e0267901. doi: 10.1371/journal.pone.0267901.
Watanabe T, Yada S, Aramaki E, Yajima H, Kizaki H, Hori S. Extracting Multiple Worries From Breast Cancer Patient Blogs Using Multilabel Classification With the Natural Language Processing Model Bidirectional Encoder Representations From Transformers: Infodemiology Study of Blogs. JMIR Cancer. 2022 Jun 3;8(2):e37840. doi: 10.2196/37840.
Kaseda D, Hashiguchi M, Kizaki H, Hori S. Latent class analysis of patients' background factors affecting the risk of specific adverse drug reactions to dipeptidyl peptidase 4 inhibitors. Int J Clin Pharmacol Ther. 2022 Jun 17. doi: 10.5414/CP204192.
Yokogawa N, Ohno-Tanaka A, Hashiguchi M, Shimizu M, Ozawa H, Ueno S, Shinoda K, Browning DJ. Early-Onset Hydroxychloroquine Retinopathy and a Possible Relationship to Blood Levels: Comment on the Article by Petri et al.Arthritis Rheumatol . 2021 Feb;73(2):358-359. doi: 10.1002/art.41497. Epub 2021 Jan 1.
Kabeya K, Satoh H, Hori S, Sawada Y. Experimental Study on Patient Preferences Regarding the Shape and Size of Medical Tablets and Capsules Using Three-Dimensionally Printed Plastic Model Formulations. Patient Prefer Adherence. 2021 Apr 28;15:863-870. doi: 10.2147/PPA.S306582.
Kido K, Ghaffar YA, Lee JC, Bianco C, Shimizu M, Shiga T, Hashiguchi M. Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus. PLoS One. 2021 Jun 4;16(6):e0252549. doi: 10.1371/journal.pone.0252549.
Ozawa H, Ueno S, Ohno-Tanaka A, Sakai T, Hashiguchi M, Shimizu M, Fujinami K, Ahn SJ, Kondo M, Browning DJ, Shinoda K, Yokogawa N. Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment. Jpn J Ophthalmol. 2021 Jul;65(4):472-481. doi: 10.1007/s10384-021-00841-9. Epub 2021 May 20.
Ito G, Kawakami K, Aoyama T, Yokokawa T, Nakamura M, Ozaka M, Sasahira N, Hashiguchi M, Kizaki H, Hama T, Hori S. Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy. PLoS One. 2021 Jul 14;16(7):e0254726. doi: 10.1371/journal.pone.0254726.
Kizaki H, Ota T, Mashima S, Nakamura Y, Kiyokawa S, Kominato H, Satoh H, Sawada Y, Hori S. Questionnaire survey investigation of the present status of dietetic consultation at community pharmacies from the perspectives of registered dietitians and pharmacists. BMC Health Serv Res. 2021 Sep 8;21(1):935. doi: 10.1186/s12913-021-06959-3.
Kizaki H, Mochizuki M, Yoshida Y, Ishikawa K, Ohishi M, Satoh H, Sawada Y, Hori S. Information provision and retrieval by registered salespersons from consumers during over-the-counter drug sales - a questionnaire survey. BMC Health Serv Res. 2021 Dec 13;21(1):1333. doi: 10.1186/s12913-021-07343-x.
Ikegami K, Hashiguchi M, Kizaki H, Yasumuro O, Funakoshi R, Hori S. Development Of Risk Prediction Model For Hypocalcemia In Bone Metastasis Patients Treated With Denosumab Plus Natural Vitamin D/Ca Supplement. ISPE's 13th Asian Conference On Pharmacoepidemiology (ACPE2021). 2021 Oct.(E-Poster)selected for Spotlight Poster
Matsuoka K, Hamada S, Shimizu M, Nanki K, Mizuno S, Kiyohara H, Arai M, Sugimoto S, Iwao Y, Ogata H, Hisamatsu T, Nagauma M, Kanai T, Mochizuki M, Hashiguchi M. Factors contributing to the systemic clearance of infliximab with long-term administration in Japanese patients with Crohn's disease: Analysis using population pharmacokinetics.Int J Clin Pharmacol Ther . 2020 Feb;58(2):89-102. doi: 10.5414/CP203569.
Kido K, Shimizu M, Shiga T, Hashiguchi M. Meta-Analysis Comparing Direct Oral Anticoagulants Versus Warfarin in Morbidly Obese Patients With Atrial Fibrillation. Am J Cardiol. 2020 Jul 1;126:23-28. doi: 10.1016/j.amjcard.2020.03.048. Epub 2020 Apr 8.
Kabeya K, Satoh H, Hori S, Miura Y, Sawada Y. Threshold Size of Medical Tablets and Capsules: Based on Information Collected by Japanese Medical Wholesaler. Patient Prefer Adherence. 2020 Jul 22;14:1251-1258. doi: 10.2147/PPA.S253663.
Kabeya K, Satoh H, Hori S, Miura Y, Sawada Y. Characteristics of "Hard-to-Use" Press-Through-Package Sheets: An Analysis of Information Collected by Marketing Specialists of a Japanese Medical Wholesaler. Patient Prefer Adherence. 2020 Jul 27;14:1267-1274. doi: 10.2147/PPA.S254040.
Kido K, Shimizu M, Shiga T, Hashiguchi M. Network Meta-Analysis Comparing Apixaban Versus Rivaroxaban in Morbidly Obese Patients With Atrial Fibrillation. Am J Cardiol. 2020 Nov 1;134:160-161. doi: 10.1016/j.amjcard.2020.09.003. Epub 2020 Sep 9.
Akiyama S, Matsuoka K, Fukuda K, Hamada S, Shimizu M, Nanki K, Mizuno S, Kiyohara H, Arai M, Sugimoto S, Iwao Y, Ogata H, Hisamatsu T, Naganuma M, Motobayashi M, Suzuki K, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Mochizuki M, Watanabe M, Hashiguchi M, Kanai T. Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. J Gastroenterol Hepatol. 2019 Oct;34(10):1751-1757. doi: 10.1111/jgh.14693. Epub 2019 Jun 26.
Kido K, Shimizu M, Hashiguchi M. Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis. J Am Pharm Assoc. 2019 May-Jun;59(3):432-438. doi: 10.1016/j.japh.2019.01.014. Epub 2019 Mar 4. PMID: 30846351.
Kaseda D,Hashiguchi M,Kizaki H,Hori S. Identification of background factors affecting the risk of specific adverse drug reactions in patients receiving dipeptidyl peptidase 4 inhibitors. ISPE's 12th Asian Conference on Pharmacoepidemiology,Kyoto, Oct 11-13, 2019.(ポスター発表)
Yokogawa N, Hashiguchi M, Nagai Y, Shimada K, Sugii S, Oshima M, Setoguchi, Shimizu M. Pharmacokinetics of hydroxychloroquine in systemic lupus erythematosus patients with renal impairment. 2019 ACR/ARP Annual Meeting,Atlanta,Georgia, USA Nov 8-13, 2019. (ポスター発表)